Literature DB >> 8252632

Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor alpha chain gene.

D Dombrowicz1, V Flamand, K K Brigman, B H Koller, J P Kinet.   

Abstract

Mast cells and basophils, which are activated by immunoglobulin E (IgE) and allergen, play a prominent role in anaphylaxis. However, they express at least three types of IgE receptor, including the high affinity IgE receptor (Fc epsilon RI). The relative contribution of these IgE receptors, and possibly other receptors such as Fc epsilon RII/CD23 and Mac-2, to the genesis of in vivo anaphylaxis is still unclear. To address this question, we have generated Fc epsilon RI-deficient mice. These mice appear normal and express a normal number of mast cells, but they are resistant to cutaneous and systemic anaphylaxis. These data demonstrate that Fc epsilon RI is necessary for the initiation of IgE-dependent anaphylactic reactions. Therefore, interfering with its function should be an effective means of treating allergy, regardless of the allergen specificity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8252632     DOI: 10.1016/0092-8674(93)90540-7

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  99 in total

1.  Natural killer cells and mast cells from gp49B null mutant mice are functional.

Authors:  S Rojo; C C Stebbins; M E Peterson; D Dombrowicz; N Wagtmann; E O Long
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

2.  Adult-derived liver stem cells acquire a cardiomyocyte structural and functional phenotype ex vivo.

Authors:  Barbara J Muller-Borer; Wayne E Cascio; Page A W Anderson; John N Snowwaert; James R Frye; Niyati Desai; Gwyn L Esch; Joe A Brackham; C Robert Bagnell; William B Coleman; Joe W Grisham; Nadia N Malouf
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

3.  Contribution of mast cells to the T helper 2 response induced by simultaneous subcutaneous and oral immunization.

Authors:  I Aoki; S Itoh; S Yokota; S Tanaka; N Ishii; K Okuda; M Minami; D M Klinman
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

4.  Differences in the Importance of Mast Cells, Basophils, IgE, and IgG versus That of CD4+ T Cells and ILC2 Cells in Primary and Secondary Immunity to Strongyloides venezuelensis.

Authors:  Kaori Mukai; Hajime Karasuyama; Kenji Kabashima; Masato Kubo; Stephen J Galli
Journal:  Infect Immun       Date:  2017-04-21       Impact factor: 3.441

5.  Hydrogen inhalation ameliorated mast cell-mediated brain injury after intracerebral hemorrhage in mice.

Authors:  Anatol Manaenko; Tim Lekic; Qingyi Ma; John H Zhang; Jiping Tang
Journal:  Crit Care Med       Date:  2013-05       Impact factor: 7.598

Review 6.  Fc receptors and their role in immune regulation and autoimmunity.

Authors:  Toshiyuki Takai
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

7.  Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity.

Authors:  Noah W Palm; Rachel K Rosenstein; Shuang Yu; Dominik D Schenten; Esther Florsheim; Ruslan Medzhitov
Journal:  Immunity       Date:  2013-10-24       Impact factor: 31.745

8.  Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergy.

Authors:  Magali Noval Rivas; Oliver T Burton; Petra Wise; Louis-Marie Charbonnier; Peter Georgiev; Hans C Oettgen; Rima Rachid; Talal A Chatila
Journal:  Immunity       Date:  2015-03-10       Impact factor: 31.745

9.  Altered inflammatory responses in leukotriene-deficient mice.

Authors:  J L Goulet; J N Snouwaert; A M Latour; T M Coffman; B H Koller
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

10.  IgG-mediated anaphylaxis via Fc gamma receptor in CD40-deficient mice.

Authors:  H Wakayama; Y Hasegawa; T Kawabe; H Saito; H Kikutani; K Shimokata
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.